RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist.
Bonhaus DW, Weinhardt KK, Taylor M, DeSouza A, McNeeley PM, Szczepanski K, Fontana DJ, Trinh J, Rocha CL, Dawson MW, Flippin LA, Eglen RM.
Bonhaus DW, et al. Among authors: eglen rm.
Neuropharmacology. 1997 Apr-May;36(4-5):621-9. doi: 10.1016/s0028-3908(97)00049-x.
Neuropharmacology. 1997.
PMID: 9225287